Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate.
Eur J Immunol. 1998 Feb;28(2):424-32. Unique Identifier : AIDSLINE MED/98180344 McSorley SJ; Rask C; Pichot R; Julia V; Czerkinsky C; Glaichenhaus N; Centre National de la Recherche Scientifique, Institut de; Pharmacologie Moleculaire et Cellulaire, Valbonne, France.; mcsor001@tc.umn.edu
Abstract:
Recent reports have suggested that after infection of BALB/c mice with Leishmania major, CD4+ T cells responding to a single antigen, LACK (Leishmania homologue of receptors for activated C kinase), drive the differentiation of other responding T cells to the Th2 phenotype and so allow lesion development to occur. Transgenic mice expressing LACK in the thymus are tolerant to LACK and thus resolve infection with L. major. The oral administration of soluble protein to mice has been shown to result in the peripheral tolerance of antigen-specific CD4+ T cells. We therefore sought to tolerize LACK reactive T cells in non-transgenic BALB/c mice in order to determine the effectiveness of this tolerization approach as an alternative to standard vaccination protocols against L. major infection. Surprisingly, oral or nasal administration of up to 8 mg of recombinant LACK did not affect the outcome of infection. We therefore conjugated LACK to cholera toxin beta subunit CTB-LACK) which has previously been shown to improve the effectiveness of oral tolerance to conjugated antigens. Nasal administration of as little as 12 microg of CTB-LACK effectively diminished the capacity of mice to mount a subsequent proliferative response to LACK and further delayed the onset of lesion development in infected mice. However, pretreatment with CTB-LACK did not prevent the eventual onset and progression of disease in these mice. An examination of cytokine responsiveness to LACK after tolerization with CTB-LACK revealed that while the Th1 response to LACK was suppressed, Th2 cytokine production was unaffected. Similar experiments using an ovalbumin-CTB conjugate suggested that this selective tolerance of Th1 cells was not specific to the LACK protein but may be an effect common to CTB-conjugated proteins.
Keywords: *Antigens, Protozoan/ADMINISTRATION & DOSAGE *Protozoan Proteins/IMMUNOLOGY *Th1 Cells/IMMUNOLOGY *Toxoids/IMMUNOLOGY *Vibrio cholerae/IMMUNOLOGY 980630
M9861774
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
